Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds

Job Details

CRA II - Permanent - HB in London

Company: Meet
Reference: APCRA080918
Closing Date: 13 Apr 18
Type: Permanent
Salary (£): 40,000 - 60,000
Benefits: car allowance

Job Summary:

CRA II (12-18 months experience) Home based in London(UK) Up to £45k pa + CA (based on experience) Small Specialist CRO Oncology, rare disease, transplant


I am  working with a specialist US CRO that is looking to take a CRA II on board due to their expansion in Europe.

The ideal candidate has experience at least in one of the following therapy ares: Oncology, Rare disease, Transplant

This role would best suit for someone with 12-18 months experience as a CRA and has been involved into all stages of clinical trials (SSV, SIV, feasibility, ideally  EC and RA submissions, on site monitoring and close out).

The newcomer will be a part of a small, niche organisation, will be provided an excellent training structure and full ownership for their studies from start up to close out. They will be working on complex and interesting studies with the flexibility to work from home.

If you are bored of doing monitoring all the time in a large corporate organisation, this vacancy is perfect for you!!

  • Salary: £45k pa + CA (based on experience)
  • Location: London, UK

(candidates require sponsorship can not be considered this time)

Contact: or 02030196028

Apply for this job: CRA II - Permanent - HB in London

Contact Information:

Address:  meet
Irongate House, 30 Dukes Place, London
Tel:  +44 203 178 7488
Website:  Visit Our Web Site

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.